Last Updated: August 2, 2026

Regcon Holdings Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for REGCON HOLDINGS

REGCON HOLDINGS has forty-seven approved drugs.

Summary for Regcon Holdings

US Patents:	0
Tradenames:	42
Ingredients:	42
NDAs:	47

Drugs and US Patents for Regcon Holdings

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Regcon Holdings	FEBUXOSTAT	febuxostat	TABLET;ORAL	210292-002	Dec 30, 2019	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Regcon Holdings	FLUOXETINE HYDROCHLORIDE	fluoxetine hydrochloride	CAPSULE;ORAL	075807-001	Jan 29, 2002		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Regcon Holdings	NEBIVOLOL HYDROCHLORIDE	nebivolol hydrochloride	TABLET;ORAL	216568-004	Mar 30, 2023	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Regcon Holdings	VARENICLINE TARTRATE	varenicline tartrate	TABLET;ORAL	219106-001	Oct 29, 2024	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Regcon Holdings	SOTALOL HYDROCHLORIDE	sotalol hydrochloride	TABLET;ORAL	207428-001	Oct 21, 2016	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Regcon Holdings	GLIMEPIRIDE	glimepiride	TABLET;ORAL	202112-001	Apr 17, 2013	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Regcon Holdings	SOTALOL HYDROCHLORIDE	sotalol hydrochloride	TABLET;ORAL	207429-003	Nov 2, 2018	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Regcon Holdings

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.